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Introduction
Fusarium spp is a common fungal mold with many subsets
found in soil, plants, and air.1,2 The fungal species is an
important plant pathogen and has become increasingly rec-
ognized as a human pathogen on account of its potential for
systemic toxicity and death in immunocompromised pa-
tients.2 Fusarium spp infections can be localized, focally
invasive, or disseminated.3 Although localized and focally
invasive infections are not uncommon in both immunocom-
petent and immunocompromised patients, dissemination of
disease is quite rare in the former population. Localized
single-organ infections generally present as keratitis, ony-
chomycosis, endophthalmitis, or cutaneous infections.
Focally invasive fungal infection is often associated with foreign
bodies from trauma or hospital catheters. Disseminated disease
usually arises in patients with hematologic malignancies and
affects the skin, lungs, and/or sinuses in most cases.4
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Abstract Introduction Fusarium spp is an omnipresent fungal species that may lead to fatal
infections in immunocompromised populations. Spontaneous intracranial infection by
Fusarium spp in immunocompetent individuals is exceedingly rare.
Case Report An immunocompetent 33-year-old Hispanic woman presented with
persistent headaches and was found to have a contrast-enhancing mass in the left
petrous apex and prepontine cistern. She underwent a subsequent craniotomy for
biopsy and partial resection that revealed a Fusarium abscess. She had a left transient
partial oculomotor palsy following the operation that resolved over the next few weeks.
She was treated with long-term intravenous antifungal therapy and remained at her
neurologic baseline 18 months following the intervention.
Discussion To our knowledge, this is the first reported case of Fusarium spp brain
abscess in an immunocompetent patient. Treatment options include surgical interven-
tion and various antifungal medications.
Conclusion This case demonstrates the rare potential of intracranial Fusarium infec-
tion in the immunocompetent host, as well as its successful treatment with surgical
aspiration and antifungal therapy.
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We report a rare case of an intracranial Fusarium spp
abscess localized in the left petrous apex and prepontine
cistern in an immunocompetent and otherwise healthy pa-
tient who lacked any known risk factors for fungal infection.
Case Report
A 33-year-old right-handed Hispanic woman presented with
a 1-year history of intermittent left-sided facial pain and
headaches. She described the pain as sharp and severe in the
left eye, head, and face. In addition, she complained of
intermittent hyperacusis of the left ear, photophobia of the
left eye, and some numbness of the left face with the pain.
Symptoms were centered mostly around the orbital and
maxillary regions of the face, and spared the mandibular
region. Her neurologist presumed that she had trigeminal
neuralgia and prescribed pregabalin. Over time, she was also
prescribed gabapentin, topiramate, and hydrocodone. There
were no traumatic events in her history, and her only
significant travel history was the occasional trip back to
Mexico to visit family.
She presented to ourhospital due to thepersistence of these
severe and refractory symptoms despite medical therapy.
Other than hypertension, she had no other significant past
medical history. Her neurologic examination on presentation
was nonfocalwith the exception of hyperacusis tofinger rub in
the left ear and hyperalgesia in the left V1 and V2 distributions.
She was afebrile with a mildly elevated erythrocyte sedimen-
tation rate of 21mm/hourandanormal C-reactiveprotein level
of 0.5mg/L. Amild leukocytosis of 14.9  109/L was attributed
to neutrophilic demargination from recent dexamethasone
therapy. Magnetic resonance imaging (MRI) of the brain
demonstrated an extra-axial contrast-enhancing mass at the
left petrous apex and prepontine cistern (►Fig. 1). Surround-
ing T2-hyperintense signal was seen in the region of the
adjacent thalamus and hypothalamus, indicative of a poten-
tially invasive process.
She underwent a left pterional craniotomy for biopsy and
partial resection. Intraoperatively, yellowish necrotic puru-
lence was noted upon incision into the lesion’s capsule
(►Fig. 2). Pathologic examination with slides stained with
hematoxylin and eosin noted hyphae (►Fig. 3) and Gomori
methenamine silver staining identified septated fungal or-
ganisms with acute angled branching (►Fig. 4). Fusarium spp
was confirmed with DNA polymerase chain reaction genetic
analysis. Following the operation, she had a transient left
oculomotor nerve palsy that resolved over the next few
weeks.
The infectious disease service at our hospital recom-
mended voriconazole, terbinafine, and amphotericin for the
findings of this invasive intracranial Fusarium fungal abscess
in the absence of a clear predisposing condition. Our patient
remained neurologically stable postoperatively with the ex-
ception of an oculomotor nerve palsy, and shewas discharged
home 4 days later with long-term intravenous triple antifun-
gal therapy and close clinical follow-up. Due to hematologic
and constitutional side effects, the infectious disease service
later deescalated the regimen to just voriconazole, which she
tolerated well. At last neurosurgical follow-up 18 months
postoperatively, her symptoms had improved and she com-
plained only of occasional migraine-like headaches, with full
resolution of her oculomotor paresis. A repeat MRI of the
brain also demonstrated nearly complete resolution of the
abscess (►Fig. 5).
Discussion
Fusarium spp are hyaline filamentous fungi that have been
reported to be the second leading cause of filamentous fungal
infection morbidity in immunocompromised transplant
Fig. 1 (A) Magnetic resonance imaging (MRI) brain axial T1-weighted contrast-enhancing image demonstrating a left petrous apex and
prepontine cistern lesion. (B) Four MRI brain coronal T1-weighted contrast-enhancing images of the same lesion.
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patients, following only Aspergillus spp.5 As a pan-global
fungus, Fusarium spp is becoming increasingly important
due to the continued increase in the incidence of infection
in the immunocompromised population. In immunocompe-
tent patients, the fungus normally presents as benign skin,
nail, or corneal infection and rarely invades or disseminates.6
There are reported to be a minimum of 69 Fusarium spp
subsets that can cause human and/or animal fusariosis, of
which F solani, F oxysporum, and F moniliforme are the most
commonly related to human pathogenesis.4,7 The most com-
monly reported portals of entry for the fungus are through
inhalation or skin trauma, with risk of dissemination associ-
ated with neutropenia and graft-versus-host disease.5
In our review of the literature, we found that Fusarium spp
pathology may present across a wide spectrum. Keratitis,8
endophthalmitis,9 onychomycosis,10,11 cutaneous infec-
tions,12,13 peritonitis,14 fungemia,15 osteomyelitis,16,17 septic
arthritis,18–20 otitis,21 sinusitis,22,23 pneumonia,24 vertebral
abscess,16 brain abscess, and other central nervous system
(CNS) infections25–34 are all possible presentations of this
fungus.4 Of general importance are those presentations that
commonly serve as portals of entry such as keratitis, endoph-
thalmitis, onychomycosis, and cutaneous infection because
these methods of fungal infection can lead to potentially fatal
dissemination; 50 to 80% mortality has been seen.4,6 Particu-
lar cases of brain abscess, vertebral abscess, and other CNS
forms of infection are noteworthy to our case. Keratitis is one
of the more common manifestations of Fusarium infection,
especially following trauma or in tropical regions of the
world. Although less frequent, keratitis is also associated
with fungal infection of contact lenses due to improper
care or inadequate cleansing by solution.8 Fungal keratitis
Fig. 3 High-power hematoxylin and eosin stained slides of the surgical
specimen demonstrating hyphae.
Fig. 2 Intraoperative still video capture of the abscess (A) prior to incision into the capsule, (B, C) during excision of the lesion, and (D) status
postresection.
Fig. 4 High-power Gomori methenamine silver stained slides con-
firming septated hyphae with acute angled branching.
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can further develop into endophthalmitis following intraoc-
ular spread. Trauma and surgery also provide routes of entry
for Fusarium spp to cause endophthalmitis.9
A review of the literature resulted in four prior confirmed
cases of Fusarium brain abscesses27,28,31,34 and several addi-
tional cases with probable brain involvement25,26,29,30,32,33
alongwith one case of vertebral abscess.16Of these cases, only
the vertebral abscess patient was immunocompetent. That
patient presented with a distant history of trauma after a
bamboo splinter, and a paravertebral abscess were removed
9 years prior at the same location of her Fusarium epidural
thoracolumbar fungal abscess. In all four confirmed cases of
brain abscesses, the patients had some type of immunosup-
pressive condition including chronic infectious mononucleo-
sis syndrome,34 recent lung transplantation,31 acute
promyelocytic leukemia,27 and acute lymphoblastic leuke-
mia.28 Parenchymal involvement was a key feature of all four
cases. In contrast, our patient’s intracranial infection was
localized primarily to the extra-axial cisternal spaces and
occurred in an immunocompetent patient.
The treatment of intracranial Fusarium spp infections is
best providedwith amultidisciplinary approach consisting of
surgical intervention and antifungal therapy. Operative re-
section is essential for debulking of the mass for symptom
relief aswell as identification of the fungal species.27Once the
fungus is identified, antifungal therapy can be initiated.
Amphotericin B and itraconazole have long been the standard
antifungal therapy, but these have been reported to have little
effect against Fusarium spp. A 2008 study by Espinel-Ingroff
et al measuring microbiologically influenced corrosion sug-
gested that voriconazole has a wide susceptibility range
against Fusarium.35 More recent case studies have suggested
the combination of voriconazole with terbinafine for success-
ful therapy against fusariosis.36
We initiated triple therapy with amphotericin B, vorico-
nazole, and terbinafine upon identification of the intracranial
fungus to cover the broad range of branching septated fungi.
After confirmation of the Fusarium organism and due to
several hematologic and constitutional side effects, our pa-
tient was deescalated to voriconazole monotherapy. She has
continued with this therapy since our last follow-up with
significant symptomatic and neuroimaging improvement.
Our patient had no known risk factors or associated
conditions that would predispose her to a suppressed im-
mune system. Even at outpatient follow-up, it was noted that
her immune function was appropriate, and notwithstanding
her intracranial fungal abscess, she continued to be in other-
wise good health.
Conclusion
We present the first reported case of a Fusarium brain abscess
in an immunocompetent patient without any known predis-
posing health conditions or prior trauma history. Invasive
Fusarium spp infection in immunocompetent patients is ex-
ceedingly uncommon, and identification of the fungus is
necessary to initiate appropriate therapy. Successful treatment
of this casewas accomplished through both surgical debulking
and antifungal drug therapy with excellent short-term results.
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